The documented research protocol is once-daily dosing in the activation phase (roughly weeks 1-4), then the same per-dose amount at a reduced 3-5x/week frequency in maintenance
Please conduct your own research before working with these compounds
The administration of NOS-blocker L-NAME and NOS-substrate L-arginine intents to control the process
We will share with you what we have told those patients, focusing on answering some of the key questions
Reported benefits (per available research): Studied in animal (rodent) models for tendon, ligament, and muscle healing, with researchers attributing effects to promotion of angiogenesis and fibroblast activity (preclinical studies from a Croatian research group at the University of Zagreb, spanning several decades) Originally investigated for gastroprotective properties
Storage Guidelines The TB500 BPC-157 Blend 20mg Vial should be stored in a cool, dry place away from direct sunlight and always kept sealed until ready for use to preserve its efficacy
